Prevention of Maternal–Fetal Transmission of Cytomegalovirus  by Adler, Stuart P.
EBioMedicine 2 (2015) 1027–1028
Contents lists available at ScienceDirect
EBioMedicine
j ourna l homepage: www.eb iomed ic ine.comCommentaryPrevention of Maternal–Fetal Transmission of CytomegalovirusStuart P. Adler
CMV Research Foundation Inc., Richmond, VA 23298, United StatesDOI of original article: http://dx.doi.org/10.1016/j.ebi
E-mail address: sadler@vcu.edu.
http://dx.doi.org/10.1016/j.ebiom.2015.08.004
2352-3964/© 2015 The Author. Published by Elsevier B.Va r t i c l e i n f o infection rate for seronegative women without exposure to children isArticle history:
Received 3 August 2015
Accepted 3 August 2015
Available online 5 August 2015
2%, but 5 to 25 times higher for exposed women (Adler et al., 2004;
Adler, 1989).
The U.S. Centers for Disease Control suggests that pregnant women
reduce their risk of CMV acquisition during pregnancy using simple
hygienic precautions but this suggestion is not often followed. Studies
demonstrating the efﬁcacy of hygienic precautions are compellingAnnually in the United States approximately 40,000 pregnant
women are infected with CMV (seroconvert) during pregnancy and
probably an equal number in Europe. Of those seroconverting during
pregnancy approximately 20% of their infants develop neurologic
damage and/or hearing deﬁcit. A hopefully ﬁnal and deﬁnitive report
by Revello et al. in this journal conﬁrms that the majority of these
infections are easily prevented by simple hygienic precautions
(Revello et al., 2015).
Between 20% and 60% of women are susceptible (seronegative) to
CMV at conception. Maternal immunity from a pre-conception CMV in-
fection protects against a second CMV infection and protects the fetuses
from severe postnatal neurosensory deafness and neurologic damage.
Thus a primary maternal infection with CMV in early pregnancy causes
the majority of congenital disease. After a primary infection during
pregnancy, the fetal infection rate varies from 33% to 75% as gestation
progresses and disease rates may be as high as 50% if infection occurs
during early gestation (Bodéus et al., 2010; Nigro et al., 2005).
The majority of seronegative pregnant women acquire CMV from a
child less than three years of age in the home or for pregnant women
employed in infant day care centers, from children in their care (Adler
et al., 2004; Adler, 1989). CMV seronegative health care providers caring
for hospitalized young children and infants, are not at an increased risk
(Adler, 2010). Infants acquire CMV in utero, via breast milk, or via
contact with other children. These CMV infected infants, unlike older
children and adults, have CMV in urine and saliva for an average of 18
months (Adler, 1991). In the US, 60% of the mothers of children in
daycare are CMV seronegative, and at least 25% of all young children
attending large group child care centers are shedding CMV. The annualom.2015.08.003.
. This is an open access article under(Revello et al., 2015; Adler et al., 1996, 2004; Finney et al., 1993;
Vauloup-Fellous et al., 2009). Our U.S. studies of CMV seronegative
pregnant women with an infected young child found that the precau-
tions were highly effective (p b 0.008) (Adler et al., 1996, 2005, 2015).
Women were told about CMV, provided written guidelines detailing
hygienic precautions, and provided a demonstration video. None
declined testing and none complained the precautions were difﬁcult
or provoked anxiety. Overall of 37 pregnant women with a child
shedding CMV, only one (3%) who received hygienic precautions
seroconverted to CMV during pregnancy. This contrasts with an infec-
tion rate of 42% for 154 non-pregnant women and women trying to
conceive who also had infected children.
A French study offered 5312 pregnant women CMV serologic
screening at 12 week gestation and 97.4% agreed (Vauloup-Fellous
et al., 2009). Seronegative women and their spouses received oral and
written hygienic precautions. For 2595 seronegative women, the rate
of maternal seroconversion during the ﬁrst 12 weeks of gestation was
compared to the rate between weeks 12 and 36. Prior to the receipt of
hygienic precautions at 12 weeks the maternal seroconversion rate
when adjusted for the number of woman–weeks observed was 0.035%
per woman–week compared to a rate of 0.008% per woman–week
after intervention (P = 0.0005). Maternal primary infections and
seroconversions were distributed evenly throughout gestation.
Revello et al. in Italy prospectively observed that of 331 CMV
seronegative pregnant women who receive oral and written hygienic
precautions for preventing CMV acquisition from a young child only
four (1.2%) women seroconverted to CMV during pregnancy (Revello
et al., 2015). In contrast of 315 women in a comparison group, CMV
infection occurred in 24 (7.6%) women during pregnancy.
In each report, the efﬁcacy of hygienic precautions has been N75%.
Given the ease and effectiveness of this intervention it is appropriate
that CMV education and hygienic precautions be implemented clinical-
ly. All pregnant women with frequent contact with a child b3 years of
age should be identiﬁed as early in gestation as possible and offered se-
rologic testing (IgG antibodies to CMV only). If seronegative, women
should be given the precautions. Subsequent testing during pregnancy
would be optional based on the level of concern of the woman andthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
1028 S.P. Adler / EBioMedicine 2 (2015) 1027–1028the results of ultrasound ﬁndings. Screening for fetal disease by
ultrasound is nearly universal in developed countries. If ultrasound
ﬁndings are normal, the risk of CMV fetal or neonatal disease is
low and hence repeat testing should be unnecessary (Nigro et al.,
2005).
In each published study women knew they were seronegative and
hence at risk. Is serologic testing necessary for motivation and for the
precautions to be effective? We do not know. Also we do not know
how often seropositive women become reinfected during pregnancy
and if maternal reinfection leads to fetal disease. These questions can
be answered in subsequent studies but are not reasons to delay
implementation of the precautions for seronegative women.
Serologic screening of high risk pregnant women for CMV is as
feasible as is current screening for syphilis, hepatitis, rubella, and HIV.
The assays for IgG to CMV have an accuracy equal or great than the
accuracy for the other infections. Serologic screening for CMV IgM or
IgG avidity should not be done.
Although seronegative health care workers are not at risk, pregnant
childcare employees are. Pregnant childcare employees should be
informed about CMV, assess their risk by serologic testing or avoid if
possible caring for children less than 2 years age for the duration of
pregnancy. The efﬁcacy of hygienic precautions for childcare employees
is unknown.
For seronegative pregnant women who are at high risk because of
exposure to a young child in the home or in large group childcare, hy-
gienic precautions are simple, inexpensive, and highly effective.Conﬂict of Interests
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